[CIS PIDD] [cis-pidd] patient with no CD40L expression

Ramsay L Fuleihan r-fuleihan at northwestern.edu
Wed Jan 30 11:16:17 EST 2013


Dear Laia,

This is a very interesting patient. How are the cells stimulated in the CD40 ligand assay and do his T cells express other stimulation markers? You may want to check T cell proliferation to PMA and ionomycin, if it is normal, then he may have a proximal signaling defect, otherwise a more distal defect.

Best,

Ramsay

Ramsay Fuleihan, MD
Associate Professor of Pediatrics
Northwestern University's Feinberg School of Medicine
Division of Allergy & Immunology
Ann & Robert H. Lurie Children’s Hospital of Chicago
225 E. Chicago Avenue Box # 60
Chicago, IL 60611
Tel: 312-227-6010
Fax: 312-227-9401
e-mail: r-fuleihan at northwestern.edu<x-msg://308/Documents%20and%20Settings/rfuleiha/Application%20Data/Microsoft/Signatures/r-fuleihan@northwestern.edu>
rfuleihan at luriechildrens.org<mailto:rfuleihan at luriechildrens.org>
www.luriechildrens.org<http://www.luriechildrens.org/>


On Jan 30, 2013, at 9:17 AM, Laia Alsina Manrique de Lara <lalsina at hsjdbcn.org<mailto:lalsina at hsjdbcn.org>> wrote:

Dear all,

I am contacting you regarding a 6-month old male with a congenital secretory diarrhoea (starting at 2 weeks of life) and hipogammaglobulinemia (detected at 2 weeks of life with absent IgG, low IgA that normalized at 4 months, and low IgM). Normal albumin, and no protein loss in stools or urine. Extensive microbiological studies have ruled out any viral, paratitic or bacterial gut infection.

IMMUNE WORKUP:
T and B cell phenotyping with no significant defects:
Absloute lymphocytes: 3500/mm3.
CD3+: 61,7% (49-85%)
CD3+CD4+: 48,6% (27-60%)
CD3+CD8+: 10,3% (10-55%)
CD19+: 23% (4-50%)
NK CD16-56+: 12,7% (2-36%)
Extended T and B cell phenotyping:
T cells alfa/beta: 92,3% (39-94%)
T cells gamma/delta: 3,6% (0,9-10%)
CD3+CD45RA+: 83% (56-95%)
CD3+CD45RO+: 12% (2-15%)
B cells IgM/IgD+: 91,9% (82-98%)
B cells IgD-: 8,1% (2-15%)
B cells IgD-CD27-: 0,8% (0,3-6%)
Bcells IgD+CD27+: 21,3% (5-50%)
Bcells IgM-CD38++: 2,9% (0-7%)

Proliferative responses to mitogens: normal proliferation to PWM, no proliferation to PHA and ConA



CD40L induction after 24h: 1,3% (5-20%).

Sanger sequence for CD40L shows no mutation. The sequence includes promoter regions.

My question is:
-which T cell deficiencies other than X-HIM could show low CD40L induction and this clinical phenotype?
We suspect a primary defect in Na+/proton transporter explaining the congenital secretory diarrhoea. Could this ion transport defect explain the primary T cell activation defect (no proliferative response to mitogens).

Thank you in advance,


Dra. Laia Alsina
Sección de Alergia e Inmunología Clínica
Hospital Sant Joan de Déu
Passeig Sant Joan de Déu nº2
08950 Esplugues de Llobregat, Barcelona
+34932804000 ext 3330

________________________________
No imprimir aquest correu ajudarà a preservar el medi ambient.
Si vostè no és el destinatari del missatge, o l'ha rebut per error, si us plau notifiqui-ho al remitent i destrueixi el missatge amb tot el seu contingut. Està prohibida la distribució no autoritzada del contingut d'aquest missatge.

No imprimir este correo ayudará a preservar el medio ambiente.
Si usted no es el destinatario del mensaje, o lo ha recibido por error, notifíquelo por favor al remitente y destruya el mensaje con todo su contenido. Está prohibida la distribución no autorizada del contenido de este mensaje.

---
The CIS-PIDD listserv is supported by:
[http://www.clinimmsoc.org/UserFiles/image/cis-pidd-list-logo_v1.jpg]
The science & practice of human immunology

P: +1.414.224.8095
E: info at clinimmsoc.org<mailto:info at clinimmsoc.org>

Not a member of CIS? Please visit www.clinimmsoc.org<https://cis.execinc.com/edibo/Signup> to join!
You are currently subscribed to cis-pidd as: r-fuleihan at northwestern.edu<mailto:r-fuleihan at northwestern.edu>.
To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183824472.6274503984d7be7c8aa2f26f787e21f8&n=T&l=cis-pidd&o=42644893
­­
---
The CIS-PIDD listserv is supported by:
[http://www.clinimmsoc.org/UserFiles/image/cis-pidd-list-logo_v1.jpg]
The science & practice of human immunology

P: +1.414.224.8095
E: info at clinimmsoc.org<mailto:info at clinimmsoc.org>

Not a member of CIS? Please visit www.clinimmsoc.org<https://cis.execinc.com/edibo/Signup> to join!
You are currently subscribed to cis-pidd as: r-fuleihan at northwestern.edu<mailto:r-fuleihan at northwestern.edu>.
To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183824472.6274503984d7be7c8aa2f26f787e21f8&n=T&l=cis-pidd&o=42644893


---
The CIS-PIDD listserv is supported by the Clinical Immunology Society
The science & practice of human immunology

P: +1.414.224.8095
E: info at clinimmsoc.org

Not a member of CIS? Please visit www.clinimmsoc.org to join!

You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183939985.3ea13d40a15475ac00ebbd9cd8a37d6d&n=T&l=cis-pidd&o=42645149
or send a blank email to leave-42645149-183939985.3ea13d40a15475ac00ebbd9cd8a37d6d at lists.clinimmsoc.org
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://seven.pairlist.net/pipermail/pagid/attachments/20130130/5acd542c/attachment.html>


More information about the PAGID mailing list